中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/03/29 | 3,915 | 3,960 | 3,885 | 3,940 | +25 | +0.6% | 941,700 |
| 2017/03/28 | 3,895 | 3,965 | 3,885 | 3,915 | +65 | +1.7% | 1,136,000 |
| 2017/03/27 | 3,830 | 3,885 | 3,830 | 3,850 | -35 | -0.9% | 856,200 |
| 2017/03/24 | 3,805 | 3,885 | 3,800 | 3,885 | +60 | +1.6% | 710,800 |
| 2017/03/23 | 3,820 | 3,835 | 3,795 | 3,825 | +5 | +0.1% | 674,900 |
| 2017/03/22 | 3,790 | 3,845 | 3,790 | 3,820 | -40 | -1% | 793,100 |
| 2017/03/21 | 3,830 | 3,875 | 3,810 | 3,860 | -10 | -0.3% | 677,100 |
| 2017/03/17 | 3,850 | 3,880 | 3,835 | 3,870 | -10 | -0.3% | 779,600 |
| 2017/03/16 | 3,860 | 3,905 | 3,850 | 3,880 | -20 | -0.5% | 596,800 |
| 2017/03/15 | 3,900 | 3,925 | 3,885 | 3,900 | -25 | -0.6% | 582,500 |
| 2017/03/14 | 3,910 | 3,945 | 3,885 | 3,925 | +15 | +0.4% | 843,100 |
| 2017/03/13 | 3,860 | 3,940 | 3,855 | 3,910 | +50 | +1.3% | 971,700 |
| 2017/03/10 | 3,800 | 3,895 | 3,800 | 3,860 | +95 | +2.5% | 1,676,900 |
| 2017/03/09 | 3,790 | 3,795 | 3,745 | 3,765 | ±0 | ±0% | 760,000 |
| 2017/03/08 | 3,800 | 3,810 | 3,755 | 3,765 | -40 | -1.1% | 790,700 |
| 2017/03/07 | 3,825 | 3,840 | 3,790 | 3,805 | -25 | -0.7% | 909,000 |
| 2017/03/06 | 3,860 | 3,870 | 3,815 | 3,830 | +10 | +0.3% | 637,200 |
| 2017/03/03 | 3,880 | 3,920 | 3,800 | 3,820 | +25 | +0.7% | 1,356,400 |
| 2017/03/02 | 3,810 | 3,845 | 3,790 | 3,795 | +30 | +0.8% | 1,282,500 |
| 2017/03/01 | 3,750 | 3,785 | 3,700 | 3,765 | +20 | +0.5% | 1,107,800 |
| 2017/02/28 | 3,750 | 3,795 | 3,735 | 3,745 | +25 | +0.7% | 1,310,100 |
| 2017/02/27 | 3,725 | 3,745 | 3,675 | 3,720 | -25 | -0.7% | 1,381,600 |
| 2017/02/24 | 3,840 | 3,850 | 3,730 | 3,745 | -155 | -4% | 1,666,600 |
| 2017/02/23 | 3,780 | 3,905 | 3,660 | 3,900 | +10 | +0.3% | 2,637,000 |
| 2017/02/22 | 3,875 | 3,905 | 3,840 | 3,890 | ±0 | ±0% | 996,200 |
| 2017/02/21 | 3,840 | 3,900 | 3,840 | 3,890 | +50 | +1.3% | 741,900 |
| 2017/02/20 | 3,850 | 3,875 | 3,825 | 3,840 | -15 | -0.4% | 923,500 |
| 2017/02/17 | 3,805 | 3,870 | 3,780 | 3,855 | +5 | +0.1% | 1,141,500 |
| 2017/02/16 | 3,875 | 3,895 | 3,830 | 3,850 | +45 | +1.2% | 1,279,400 |
| 2017/02/15 | 3,870 | 3,895 | 3,800 | 3,805 | +40 | +1.1% | 978,000 |
| 2017/02/14 | 3,810 | 3,810 | 3,760 | 3,765 | -60 | -1.6% | 1,054,600 |
| 2017/02/13 | 3,795 | 3,885 | 3,795 | 3,825 | +45 | +1.2% | 1,256,100 |
| 2017/02/10 | 3,755 | 3,800 | 3,740 | 3,780 | +95 | +2.6% | 1,379,600 |
| 2017/02/09 | 3,660 | 3,705 | 3,645 | 3,685 | ±0 | ±0% | 775,800 |
| 2017/02/08 | 3,680 | 3,710 | 3,670 | 3,685 | +5 | +0.1% | 565,400 |
| 2017/02/07 | 3,685 | 3,710 | 3,670 | 3,680 | -35 | -0.9% | 716,300 |
| 2017/02/06 | 3,760 | 3,775 | 3,670 | 3,715 | -15 | -0.4% | 861,000 |
| 2017/02/03 | 3,690 | 3,755 | 3,665 | 3,730 | +25 | +0.7% | 1,729,500 |
| 2017/02/02 | 3,615 | 3,810 | 3,605 | 3,705 | +300 | +8.8% | 3,775,000 |
| 2017/02/01 | 3,355 | 3,445 | 3,300 | 3,405 | +105 | +3.2% | 1,475,600 |
| 2017/01/31 | 3,325 | 3,350 | 3,280 | 3,300 | -45 | -1.3% | 1,174,000 |
| 2017/01/30 | 3,360 | 3,360 | 3,310 | 3,345 | -30 | -0.9% | 1,088,800 |
| 2017/01/27 | 3,385 | 3,405 | 3,355 | 3,375 | ±0 | ±0% | 1,039,900 |
| 2017/01/26 | 3,335 | 3,385 | 3,325 | 3,375 | +40 | +1.2% | 1,131,500 |
| 2017/01/25 | 3,315 | 3,350 | 3,305 | 3,335 | +10 | +0.3% | 781,000 |
| 2017/01/24 | 3,335 | 3,375 | 3,315 | 3,325 | -25 | -0.7% | 1,048,900 |
| 2017/01/23 | 3,370 | 3,385 | 3,340 | 3,350 | -60 | -1.8% | 1,162,200 |
| 2017/01/20 | 3,390 | 3,430 | 3,380 | 3,410 | -5 | -0.1% | 810,900 |
| 2017/01/19 | 3,400 | 3,445 | 3,400 | 3,415 | +20 | +0.6% | 901,700 |
| 2017/01/18 | 3,400 | 3,405 | 3,360 | 3,395 | -10 | -0.3% | 922,300 |
2001～
2050
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 771,100円 | +1.7% | +5.0% | 3.24% | 30.95倍 | 6.67倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 武 田 | 434,700円 | -1.1% | +75.3% | 4.60% | 29.78倍 | 0.98倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 第一三共 | 354,000円 | +6.0% | +4.0% | 2.20% | 21.98倍 | 4.06倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 大塚ＨＤ | 721,000円 | +2.2% | +10.2% | 1.66% | 13.85倍 | 1.39倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 140,400円 | +0.9% | +380.2% | 5.56% | 19.34倍 | 1.66倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
